4 CROI Briefs
Another year of the Conference on Retroviruses and Opportunistic Infections (CROI 2016) has come to pass. Here are a few less publicized but important...
Interferon & HIV
Luis J. Montaner DVM, D.Phil, of the Wistar Institute in Philadelphia, Pennsylvania has been studying the effects of interferon on HIV DNA and its...
Targeting HIV Reservoirs
Hiding Place
One focus of the amfAR 2016 CURE Summit targeted HIV reservoirs
by Jeannie Wraight
This year, amfAR marked World AIDS Day with the 2016 HIV...
Orphaned Vaccines
Sometimes viewing a complex issue in its most simplistic form can help us to understand where a problem lies. HIV is a virus that...
Vpu Inhibitor Candidate
BIT225 is a new type of antiviral called a Vpu inhibitor, which researchers are investigating to treat both HIV and HIV/hepatitis C (HCV) co-infection....
IV Drug Users & HIV Vaccine Response
Everyone Counts
Differences in intravenous drug users may affect their response to an HIV vaccine
by Jeannie Wraight
Prevention strategies such as Treatment as Prevention, PrEP, syringe...
Checking the Map
LifeGuide
Destination: Cure
Checking the Map
Where are we on the road to a cure?
by Jeannie Wraight
The past year has been wrought with disappointment on the HIV...
BIT225: HIV VPU Inhibitor Candidate
Contender in the Ring
A novel HIV therapy targets & eradicates one cell type in the viral reservoir
by Jeannie Wraight
BIT225, an HIV VPU inhibitor, has...
Countdown to a Cure
by Jeannie Wraight
As part of the Countdown to a Cure Initiative, amfAR (The Foundation for AIDS Research) will direct $20 million, of a $100...
Translation Inhibitors as Therapeutic Strategy
Cure Research with a Heart
Translation inhibitors may be part of a therapeutic strategy
by Jeannie Wraight
To date there are over 100 documented cases of HIV...
LATEST POSTS
Maid Service: Review
Maid Service
by John Whittier Treat
JMS Books
Reviewed by Chael Needle
In the mid-eighties, 1985 or 1986, but perhaps slightly earlier, my brother Doug’s friend Glenn traveled...
